By inhibiting the proliferation and activation of pro-inflammatory Th1 and Th17 cells, adiponectin prevents the excessive secretion of IFN-γ and IL-17, which are known to exacerbate sepsis-induced inflammation as well. Here, ADIPOQ is linked to Sepsis.